Michael Meluzio
Fortune : 1 M $ au 31/08/2026
Fortune : 1 M $ au 31/08/2026
Mr. Michael Meluzio, CPA, is a Chief Accounting Officer & Vice President at Cue Biopharma, Inc. Mr. Meluzio was previously employed as a Chief Financial & Accounting Officer by Kiora Pharmaceuticals, Inc. He received his undergraduate degree from Adelphi University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,67% | 13/08/2026 | 48 961 ( 0,67% ) | 1 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CUE BIOPHARMA, INC. | Comptroller/Controller/Auditor | 01/06/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 18/03/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Adelphi University
Adelphi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national